A Mumbai company is working on a potential coronavirus medicine

Favipiravir, an off-patent drug originally owned by Japanese drug maker Fuji, holds potential against RNA viruses, one of which is Covid-19. The World Health Organisation has listed this drug as part of its experimental protocol for treating the disease. Lasa SuperGenerics, a manufacturer of active pharmaceutical ingredients, has started work on it.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3dd8dvv
via IFTTT